Future prospective studies are required to fully elucidate the long-term impact of high exogenous testosterone levels on endometrial cancer risk in TMGD individuals, considering the interplay of androgen receptors, histological subtypes, and hormone pathways. This evidence concerns the gene AR and endometrial cancer.